首页 > 最新文献

April 2021最新文献

英文 中文
MANAGEMENT OF MIGRAINE THROUGH PANCHKARMA - A CASE STUDY 通过因果报应管理偏头痛-个案研究
Pub Date : 2021-04-15 DOI: 10.46607/iamj3909042021
S. Sunita, Aakanksha Sharma, M. Sharma, G. Sharma
Ardhavabhedaka is a type of Shiroroga. It is unilateral headache with Compli- cations of blindness and hearing loss. It can be clinically correlated with migraine based on clinical manifestation.Affecting at least 1 adult in every 7 in the world (WHO). It is 3 time more common in women than men. it causes moderate to severe pain that is throbbing or pulsating, requiring long-term management. It causes personal suffer- ing, impaired quality of life and high financial cost. Nasya Karma and Shirodhara are the prime treatment modalities for Shirogata disease. A 19 year old girl patient came to OPD with complaining of severe headache. Shirodhara done with milk + Dashmool - Kwath and Mahanarayan tail. After done this Panchkarma treatment patient got highlysignificant relief in the cardinal symptoms of Ardhavabhedaka.Keywords: Migraine, Ardhavbhaedaka, Shirodhara
Ardhavabhedaka是Shiroroga的一种。该病为单侧头痛,伴有失明和听力丧失。可根据临床表现与偏头痛进行临床相关性分析。世界上每7名成年人中至少有1人受到影响(世卫组织)。女性的发病率是男性的3倍。它会引起中度至重度的悸动或搏动性疼痛,需要长期治疗。它造成个人痛苦,生活质量受损和高经济成本。那西雅噶玛和湿原是湿泻病的主要治疗方式。一名19岁的女病人来门诊,主诉头痛严重。Shirodhara做牛奶+ Dashmool - Kwath和Mahanarayan尾巴。在做了这种缘业治疗后,病人的主要症状得到了显著的缓解。关键词:偏头痛,阿德哈巴德卡,释罗原
{"title":"MANAGEMENT OF MIGRAINE THROUGH PANCHKARMA - A CASE STUDY","authors":"S. Sunita, Aakanksha Sharma, M. Sharma, G. Sharma","doi":"10.46607/iamj3909042021","DOIUrl":"https://doi.org/10.46607/iamj3909042021","url":null,"abstract":"Ardhavabhedaka is a type of Shiroroga. It is unilateral headache with Compli- cations of blindness and hearing loss. It can be clinically correlated with migraine based on clinical manifestation.\u0000Affecting at least 1 adult in every 7 in the world (WHO). It is 3 time more common in women than men. it causes moderate to severe pain that is throbbing or pulsating, requiring long-term management. It causes personal suffer- ing, impaired quality of life and high financial cost. Nasya Karma and Shirodhara are the prime treatment modalities for Shirogata disease. A 19 year old girl patient came to OPD with complaining of severe headache. Shirodhara done with milk + Dashmool - Kwath and Mahanarayan tail. After done this Panchkarma treatment patient got highlysignificant relief in the cardinal symptoms of Ardhavabhedaka.\u0000Keywords: Migraine, Ardhavbhaedaka, Shirodhara","PeriodicalId":8309,"journal":{"name":"April 2021","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73845469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MANAGMENT OF MULTIPLE SCLEROSIS THROUGH THE RAY OF AYURVEDIC PRINCIPLE: A CASE STUDY 通过阿育吠陀原理治疗多发性硬化症:个案研究
Pub Date : 2021-04-15 DOI: 10.46607/iamj3709042021
M. Mukta, Manjula Karlwad
Autoimmune disease occurs when the immune system attacks self-molecules as a result of a breakdown of immu- nological tolerance to auto reactive immune cells. Autoimmune disorders are on the rise globally and affect 8.5% of the population worldwide. In that one among is Multiple Sclerosis (MS)2 is a chronic progressive disease with a variety of cognitive, motor and sensory deficits. In Ayurveda, Multiple Sclerosis can be correlated to Pranaavruta Vyana3, all autoimmune diseases are the result of Amavisha and ama utpatti.4 Modern treatments like immuno- suppressant, corticosteroids, stem cell therapy are highly expensive when compared to Ayurvedic management. The scope of Ayurvedic Management and preventive aspect mainly concentrates on Ama Pachana, Agni Deepana, Doshavashechana, Shesha Dosha Shamana and followed by Rasayana, which in turn improves the quality of life and life expectancy.Keywords: Autoimmune disorders, Multiple Sclerosis, Pranaavruta Vyana, Ama
自身免疫性疾病是由于免疫系统对自身反应性免疫细胞免疫耐受的破坏而攻击自身分子。自身免疫性疾病在全球范围内呈上升趋势,影响到全球8.5%的人口。多发性硬化症(MS)是一种慢性进行性疾病,伴有各种认知、运动和感觉缺陷。在阿育吠陀中,多发性硬化症可以与Pranaavruta vyan3相关,所有自身免疫性疾病都是Amavisha和ama utpatti的结果与阿育吠陀治疗相比,免疫抑制剂、皮质类固醇、干细胞治疗等现代治疗方法非常昂贵。阿育吠陀管理和预防方面的范围主要集中在Ama Pachana, Agni Deepana, Doshavashechana, Shesha Dosha Shamana以及随后的Rasayana,这反过来又提高了生活质量和预期寿命。关键词:自身免疫性疾病,多发性硬化,Pranaavruta Vyana, Ama
{"title":"MANAGMENT OF MULTIPLE SCLEROSIS THROUGH THE RAY OF AYURVEDIC PRINCIPLE: A CASE STUDY","authors":"M. Mukta, Manjula Karlwad","doi":"10.46607/iamj3709042021","DOIUrl":"https://doi.org/10.46607/iamj3709042021","url":null,"abstract":"Autoimmune disease occurs when the immune system attacks self-molecules as a result of a breakdown of immu- nological tolerance to auto reactive immune cells. Autoimmune disorders are on the rise globally and affect 8.5% of the population worldwide. In that one among is Multiple Sclerosis (MS)2 is a chronic progressive disease with a variety of cognitive, motor and sensory deficits. In Ayurveda, Multiple Sclerosis can be correlated to Pranaavruta Vyana3, all autoimmune diseases are the result of Amavisha and ama utpatti.4 Modern treatments like immuno- suppressant, corticosteroids, stem cell therapy are highly expensive when compared to Ayurvedic management. The scope of Ayurvedic Management and preventive aspect mainly concentrates on Ama Pachana, Agni Deepana, Doshavashechana, Shesha Dosha Shamana and followed by Rasayana, which in turn improves the quality of life and life expectancy.\u0000Keywords: Autoimmune disorders, Multiple Sclerosis, Pranaavruta Vyana, Ama","PeriodicalId":8309,"journal":{"name":"April 2021","volume":"101 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75824571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EFFICACY OF KSHEERABASTI IN THE MANAGEMENT OF GARBHAKSHAYA W.S.R. TO INTRAUTERINE GROWTH RETARTDATION - A CASE REPORT ksheerabasti治疗garbhakshaya ws.r.宫内发育迟缓1例
Pub Date : 2021-04-15 DOI: 10.46607/iamj4309042021
S. Choudhary, S. Sonu, B. K., Vipin Tanwar
Intrauterine growth restriction is quite common condition now a days and needs intensive fetal surveillance and proper antepartum and intra-partum care. IUGR may result in significant fetal morbidity and mortality if not properly diagnosed and treated. The condition is most commonly caused by inadequate maternal-fetal circulation, resulting in decrease in fetal growth. In Ayurveda, IUGR can be considered under Garbhakshaya. In Garbhakshaya according to Acharya Sushruta, Garbhaaspandana and Anunatkukshitta mentioned which is mainly due to the inadequate nutrition to fetus. Acharya Sushruta has mentioned the usage of Ksheerabasti from 8th month onwards to nourish the fetus in Garbhakshaya. In present case study, A 29-year-old pregnant woman with period of gestation 37 weeks 1 day was came to OPD of PTSR dept. National institute of Ayurveda (Deemed to be university). On examination her fundal height was found less than period of amenorrhoea. USG report showed single live intrauterine pregnancy of 35 weeks 3 days with IUGR and extensive calcification in placenta, was treated with Ksheerabasti, administered for 10 days once in the morning in the dose of 450 ml per day. After 10 days of above said treatment USG report was repeated and marked improvement was observed with no calcification and a healthy baby was delivered with normal Apgar score. So here Shatavari, Vidarikanda and Yashtimadhu sadhita Ksheerabasti is very effective treatment modality to improve IUGR and for good nourishment of fetus.Keywords: Garbhakshaya, IUGR, Ksheerabasti, Shatavari, Vidarikanda, Yashtimadhu etc.
宫内生长受限是当今非常普遍的情况,需要密切的胎儿监测和适当的产前和产中护理。如果诊断和治疗不当,IUGR可能导致严重的胎儿发病率和死亡率。这种情况最常见的原因是母胎循环不足,导致胎儿生长下降。在阿育吠陀,IUGR可以被认为是Garbhakshaya。在Garbhakshaya中,根据Acharya Sushruta, Garbhaaspandana和Anunatkukshitta提到这主要是由于胎儿营养不足。Acharya Sushruta提到从第8个月开始使用Ksheerabasti来滋养Garbhakshaya的胎儿。在本病例研究中,一名29岁妊娠期37周1天的孕妇来到阿育吠陀国立研究所(被认为是大学)PTSR部的门诊。经检查发现她的子宫高度小于闭经期。USG报告显示,单次活宫内妊娠35周3天,IUGR和胎盘广泛钙化,用Ksheerabasti治疗,10天,每天早晨一次,剂量为450 ml。在上述治疗10天后,重复USG报告,观察到明显的改善,没有钙化,健康的婴儿出生,Apgar评分正常。因此,Shatavari, Vidarikanda和Yashtimadhu sadhita Ksheerabasti是非常有效的治疗方式,可以改善IUGR并为胎儿提供良好的营养。关键词:Garbhakshaya, IUGR, Ksheerabasti, Shatavari, Vidarikanda, Yashtimadhu等
{"title":"EFFICACY OF KSHEERABASTI IN THE MANAGEMENT OF GARBHAKSHAYA W.S.R. TO INTRAUTERINE GROWTH RETARTDATION - A CASE REPORT","authors":"S. Choudhary, S. Sonu, B. K., Vipin Tanwar","doi":"10.46607/iamj4309042021","DOIUrl":"https://doi.org/10.46607/iamj4309042021","url":null,"abstract":"Intrauterine growth restriction is quite common condition now a days and needs intensive fetal surveillance and proper antepartum and intra-partum care. IUGR may result in significant fetal morbidity and mortality if not properly diagnosed and treated. The condition is most commonly caused by inadequate maternal-fetal circulation, resulting in decrease in fetal growth. In Ayurveda, IUGR can be considered under Garbhakshaya. In Garbhakshaya according to Acharya Sushruta, Garbhaaspandana and Anunatkukshitta mentioned which is mainly due to the inadequate nutrition to fetus. Acharya Sushruta has mentioned the usage of Ksheerabasti from 8th month onwards to nourish the fetus in Garbhakshaya. In present case study, A 29-year-old pregnant woman with period of gestation 37 weeks 1 day was came to OPD of PTSR dept. National institute of Ayurveda (Deemed to be university). On examination her fundal height was found less than period of amenorrhoea. USG report showed single live intrauterine pregnancy of 35 weeks 3 days with IUGR and extensive calcification in placenta, was treated with Ksheerabasti, administered for 10 days once in the morning in the dose of 450 ml per day. After 10 days of above said treatment USG report was repeated and marked improvement was observed with no calcification and a healthy baby was delivered with normal Apgar score. So here Shatavari, Vidarikanda and Yashtimadhu sadhita Ksheerabasti is very effective treatment modality to improve IUGR and for good nourishment of fetus.\u0000Keywords: Garbhakshaya, IUGR, Ksheerabasti, Shatavari, Vidarikanda, Yashtimadhu etc.","PeriodicalId":8309,"journal":{"name":"April 2021","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87026547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A LITERATURE STUDY TO UNDERSTAND PHYSIOLOGY OF PRE VENEPUNCTURE-POSITION OF LEGS W.S.R TO SUSHRUT SAMHITA 了解静脉穿刺前的生理学——腿的位置W.S.R,以达到解脱的目的
Pub Date : 2021-04-15 DOI: 10.46607/iamj1009042021
Khan Rohee Wadoodkhan
Position of a patient in surgical procedures, clinical examinations is an important assisting factor. Position of patient in minor and major surgical procedures is mentioned in ayurveda as well as modern surgery. One of such position is mentioned in Sushrut samhita sharirsthan chapter 8 and shloka number 8. This reference is about siraa utthaan before siravedh / venepuncture / bloodletting procedure. Before this procedure a position is given to patient by doctor. This study is about review of physiological changes in venous blood flow due to position of legs, use of bandhan [like tourniquet], location of bandhan from venepuncture site and effect of these techniques on veins and venous blood volume. Vein should be prominent and full of blood [sira utthaan] i.e., expected before bloodletting treatments/procedures.Keywords: sira vedh, veins in legs, venous blood volume in legs, sira utthaan, bloodletting in legs
在手术过程中,病人的体位是临床检查的重要辅助因素。在阿育吠陀和现代外科手术中都提到了病人在小手术和大手术中的位置。其中一个这样的位置在Sushrut samhita sharirsthan第8章和shloka第8号中提到。这篇文章是关于在静脉穿刺/放血手术之前的siraa utthan。在这个程序之前,医生给病人一个位置。本研究综述了下肢位置、绷带(如止血带)的使用、绷带在静脉穿刺部位的位置以及这些技术对静脉和静脉血容量的影响对静脉血流的生理变化。静脉应突出且充满血液,即在放血治疗/程序之前预期。关键词:紫檀,腿部静脉,腿部静脉血容量,紫檀,腿部放血
{"title":"A LITERATURE STUDY TO UNDERSTAND PHYSIOLOGY OF PRE VENEPUNCTURE-POSITION OF LEGS W.S.R TO SUSHRUT SAMHITA","authors":"Khan Rohee Wadoodkhan","doi":"10.46607/iamj1009042021","DOIUrl":"https://doi.org/10.46607/iamj1009042021","url":null,"abstract":"Position of a patient in surgical procedures, clinical examinations is an important assisting factor. Position of patient in minor and major surgical procedures is mentioned in ayurveda as well as modern surgery. One of such position is mentioned in Sushrut samhita sharirsthan chapter 8 and shloka number 8. This reference is about siraa utthaan before siravedh / venepuncture / bloodletting procedure. Before this procedure a position is given to patient by doctor. This study is about review of physiological changes in venous blood flow due to position of legs, use of bandhan [like tourniquet], location of bandhan from venepuncture site and effect of these techniques on veins and venous blood volume. Vein should be prominent and full of blood [sira utthaan] i.e., expected before bloodletting treatments/procedures.\u0000Keywords: sira vedh, veins in legs, venous blood volume in legs, sira utthaan, bloodletting in legs","PeriodicalId":8309,"journal":{"name":"April 2021","volume":"77 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76581595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CONCEPTUAL ANALYSIS OF SEX DETERMINATION OR LING NIRDHARANA IN AYURVEDA 阿育吠陀中性别决定或灵nirdharana的概念分析
Pub Date : 2021-04-15 DOI: 10.46607/iamj1809042021
Pinki Maheshwari, Gyanadutta Pradhan, Sunita Kumari, Arvind Kumar
All parents have a dream of be getting the healthy, intellectual and beautiful progeny this is also evident from the reference of the word like “Suputrakameeya” in classics. Ayurveda describes simple methods to produce a healthy offspring and the planning of which starts from the selection of partners. Many factors mentioned in Ayurveda towards the study of development of foetus including fertilization and sex determination, Ayurveda considered two basic factors in the development of human beings i.e., Shukra and Shonita it represents the sperm and ovum in modern medical science and which are responsible for the fertilization. Nearly all Acharyas like Charaka and Sushruta have recognised the three different types of sexes viz. Puman (male), Stri (female) and Napunsaka (hermaphrodite). In these contexts, Charaka clearly stated that dominance of Shonita during conception resulting procreation of female child and dominance of Shukra (sperm) leads to male child. The sex of an individual is determined by the X and Y chromosome. But sex determination mainly depends on the Y chromosome. It has been seen the individuals with a Y chromosome develop male characteristics and individuals without a Y chromosome develop female characteristics.Keywords: Shukra, Shonita, Puman, Stri
所有的父母都有一个梦想,就是得到一个健康、聪明、美丽的后代,这也从经典中“Suputrakameeya”这个词的引用中得到了证明。阿育吠陀描述了产生健康后代的简单方法,计划从选择伴侣开始。阿育吠陀提到了许多因素来研究胎儿的发育,包括受精和性别决定,阿育吠陀认为人类发育的两个基本因素,即Shukra和Shonita,它在现代医学中代表精子和卵子,它们负责受精。几乎所有的阿查里亚人,如查拉卡和苏舒鲁塔,都认识到三种不同的性别,即普曼(男性)、斯特里(女性)和纳普恩萨卡(雌雄同体)。在这些背景下,查拉卡清楚地指出,在受孕期间,Shonita的优势导致了女孩的生育,而Shukra(精子)的优势导致了男孩的生育。个体的性别是由X染色体和Y染色体决定的。但性别决定主要取决于Y染色体。有Y染色体的个体发育为男性特征,而没有Y染色体的个体发育为女性特征。关键词:Shukra, Shonita, Puman, Stri
{"title":"CONCEPTUAL ANALYSIS OF SEX DETERMINATION OR LING NIRDHARANA IN AYURVEDA","authors":"Pinki Maheshwari, Gyanadutta Pradhan, Sunita Kumari, Arvind Kumar","doi":"10.46607/iamj1809042021","DOIUrl":"https://doi.org/10.46607/iamj1809042021","url":null,"abstract":"All parents have a dream of be getting the healthy, intellectual and beautiful progeny this is also evident from the reference of the word like “Suputrakameeya” in classics. Ayurveda describes simple methods to produce a healthy offspring and the planning of which starts from the selection of partners. Many factors mentioned in Ayurveda towards the study of development of foetus including fertilization and sex determination, Ayurveda considered two basic factors in the development of human beings i.e., Shukra and Shonita it represents the sperm and ovum in modern medical science and which are responsible for the fertilization. Nearly all Acharyas like Charaka and Sushruta have recognised the three different types of sexes viz. Puman (male), Stri (female) and Napunsaka (hermaphrodite). In these contexts, Charaka clearly stated that dominance of Shonita during conception resulting procreation of female child and dominance of Shukra (sperm) leads to male child. The sex of an individual is determined by the X and Y chromosome. But sex determination mainly depends on the Y chromosome. It has been seen the individuals with a Y chromosome develop male characteristics and individuals without a Y chromosome develop female characteristics.\u0000Keywords: Shukra, Shonita, Puman, Stri","PeriodicalId":8309,"journal":{"name":"April 2021","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86923949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A REVIEW ON ROLE OF VACHA ARKA KARNAPOORANA IN BADHIRYA W.S.R TO SENSORY NEURAL HEARING LOSS 巴垂亚区vacha arka karnapoorana在感觉神经性听力损失中的作用综述
Pub Date : 2021-04-15 DOI: 10.46607/iamj1509042021
Insha M. I. Ansari, Savita S. Angadi
Ear is a very important sensory organ of hearing. Loss of hearing has a very negative impact on one’s social, pro- fessional and personal life. According to WHO (1st March 2020), there are over 5% of the world’s population are suffering from hearing loss. It is estimated that by the year 2050, 1 in every 10 people will have hearing loss. There are many modern interventions which have been used nowadays like hearing aids, etc. But it is not possible for everyone to afford such treatment. To provide effective and alternative treatment for the betterment of society with simple and less expensive local administrative treatment with the help of Ayurvedic modalities i.e. Karnapoorana (instillation of medicated volatile oil into external auditory canal) of Bilwa Taila (Bilwa oil), Katu Taila (Katu oil), Arka (volatile oil), etc. Arkas are prepared by the combination of Jala (water) and Agni (fire) and it assimilates in the body very quickly, hence it can be used in the management of Badhirya (dwindle hearing). Considering all this, the study is planned for the Evaluation of Vacha Arka Karnapoorana in Badhirya W.S.R. To Sensory Neural Hear- ing Loss.Keywords: Sensorineural hearing loss, Vacha Arka, Badhirya, Karnapoorana.
耳朵是一个非常重要的听觉感觉器官。听力损失对一个人的社会、职业和个人生活都有非常负面的影响。根据世卫组织(2020年3月1日)的数据,全球超过5%的人口患有听力损失。据估计,到2050年,每10人中就有1人会有听力损失。现在有许多现代干预手段,如助听器等。但不是每个人都能负担得起这种治疗。在阿育吠陀模式的帮助下,通过简单而廉价的地方行政治疗,即Bilwa Taila (Bilwa油),Katu Taila (Katu油),Arka(挥发油)等的Karnapoorana(向外耳道注入药用挥发油),为改善社会提供有效的替代治疗。Arkas是由Jala(水)和Agni(火)结合而成的,它在体内吸收得非常快,因此它可以用于治疗Badhirya(减少听力)。考虑到这一切,本研究计划用于评价巴德里亚地区Vacha Arka Karnapoorana对感觉神经性听力损失的影响。关键词:感音神经性听力损失,Vacha Arka, Badhirya, Karnapoorana
{"title":"A REVIEW ON ROLE OF VACHA ARKA KARNAPOORANA IN BADHIRYA W.S.R TO SENSORY NEURAL HEARING LOSS","authors":"Insha M. I. Ansari, Savita S. Angadi","doi":"10.46607/iamj1509042021","DOIUrl":"https://doi.org/10.46607/iamj1509042021","url":null,"abstract":"Ear is a very important sensory organ of hearing. Loss of hearing has a very negative impact on one’s social, pro- fessional and personal life. According to WHO (1st March 2020), there are over 5% of the world’s population are suffering from hearing loss. It is estimated that by the year 2050, 1 in every 10 people will have hearing loss. There are many modern interventions which have been used nowadays like hearing aids, etc. But it is not possible for everyone to afford such treatment. To provide effective and alternative treatment for the betterment of society with simple and less expensive local administrative treatment with the help of Ayurvedic modalities i.e. Karnapoorana (instillation of medicated volatile oil into external auditory canal) of Bilwa Taila (Bilwa oil), Katu Taila (Katu oil), Arka (volatile oil), etc. Arkas are prepared by the combination of Jala (water) and Agni (fire) and it assimilates in the body very quickly, hence it can be used in the management of Badhirya (dwindle hearing). Considering all this, the study is planned for the Evaluation of Vacha Arka Karnapoorana in Badhirya W.S.R. To Sensory Neural Hear- ing Loss.\u0000Keywords: Sensorineural hearing loss, Vacha Arka, Badhirya, Karnapoorana.","PeriodicalId":8309,"journal":{"name":"April 2021","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91061593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A ROLE OF AYURVEDIC MANAEGEMENT IN INSULIN DEPENDENT DIABETES MELLITUS: A CASE STUDY 阿育吠陀治疗在胰岛素依赖型糖尿病中的作用:一个案例研究
Pub Date : 2021-04-15 DOI: 10.46607/iamj3609042021
Vidhi Patel, Dhaval Dholakiya, Manish V. Patel
Diabetes Mellitus is one of the of the most common non communicable or lifestyle disease globally. In Ayurveda this condition can be correlate with Madhumeha. It is one type of Prameha where the patient passes honey like urine. Prevalence of diabetes mellitus is rapidly rising throughout the world, where India leads with largest num- ber of diabetes. In Ayurveda Madhumeha is explained as Asadhya but also gives treatment for it. Ayurveda can be useful in the treatment of diabetes and associated complications. Sodhan and Shaman both are useful in the treat- ment of Madhumeha. A 64 years old male patient known case of Insulin dependent diabetes mellitus was visited in OPD of P. D. Patel Ayurveda Hospital, Nadiad. He had complaints of weakness, pain in both knee joint and shoulder joint with back pain since 10 years. Patient was on regular allopathic medicine for 10 year but he did not got any satisfactory relief in the sign and symptoms. His blood glucose level also not under control. He was treated for 28 days in I.P.D. treatment then after O.P.D. treatment also given. After treatment a significant improvement was noted in patient’s signs and symptoms. His blood glucose level also under control even after insulin therapy and hypoglycemic drugs were stopped. There was 80% relief after I.P.D. and O.P.D. treatment.Keywords: Diabetes, Madhumeha, Sodhan, Shamana, Blood glucose.
糖尿病是全球最常见的非传染性疾病或生活方式疾病之一。在阿育吠陀中,这种情况可能与Madhumeha有关。这是Prameha的一种,患者会像尿一样排出蜂蜜。糖尿病的患病率在世界范围内迅速上升,其中印度是糖尿病人数最多的国家。在阿育吠陀中,Madhumeha被解释为Asadhya,但也给予治疗。阿育吠陀在治疗糖尿病和相关并发症方面很有用。Sodhan和Shaman在治疗Madhumeha时都很有用。一名64岁男性胰岛素依赖型糖尿病患者在纳迪亚德帕特尔阿育吠陀医院门诊就诊。自10年以来,他一直有虚弱,膝关节和肩关节疼痛,背部疼痛。患者接受常规对症治疗10年,但症状和体征没有得到满意的缓解。他的血糖水平也没有得到控制。患者接受了28天的ipd治疗,之后又接受了opd治疗。治疗后,患者的体征和症状均有显著改善。即使在停止胰岛素治疗和降糖药后,他的血糖水平也得到了控制。ipd和opd治疗后缓解了80%。关键词:糖尿病,Madhumeha, Sodhan, Shamana,血糖
{"title":"A ROLE OF AYURVEDIC MANAEGEMENT IN INSULIN DEPENDENT DIABETES MELLITUS: A CASE STUDY","authors":"Vidhi Patel, Dhaval Dholakiya, Manish V. Patel","doi":"10.46607/iamj3609042021","DOIUrl":"https://doi.org/10.46607/iamj3609042021","url":null,"abstract":"Diabetes Mellitus is one of the of the most common non communicable or lifestyle disease globally. In Ayurveda this condition can be correlate with Madhumeha. It is one type of Prameha where the patient passes honey like urine. Prevalence of diabetes mellitus is rapidly rising throughout the world, where India leads with largest num- ber of diabetes. In Ayurveda Madhumeha is explained as Asadhya but also gives treatment for it. Ayurveda can be useful in the treatment of diabetes and associated complications. Sodhan and Shaman both are useful in the treat- ment of Madhumeha. A 64 years old male patient known case of Insulin dependent diabetes mellitus was visited in OPD of P. D. Patel Ayurveda Hospital, Nadiad. He had complaints of weakness, pain in both knee joint and shoulder joint with back pain since 10 years. Patient was on regular allopathic medicine for 10 year but he did not got any satisfactory relief in the sign and symptoms. His blood glucose level also not under control. He was treated for 28 days in I.P.D. treatment then after O.P.D. treatment also given. After treatment a significant improvement was noted in patient’s signs and symptoms. His blood glucose level also under control even after insulin therapy and hypoglycemic drugs were stopped. There was 80% relief after I.P.D. and O.P.D. treatment.\u0000Keywords: Diabetes, Madhumeha, Sodhan, Shamana, Blood glucose.","PeriodicalId":8309,"journal":{"name":"April 2021","volume":"144 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76810066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AYURVEDA UNDERSTANDING OF KATISHULA (LOW BACK PAIN) AS A VYADHI OR LAKSHANA: A HISTORICAL REVIEW 阿育吠陀对katishula(腰痛)的理解是vyadhi或lakshana:历史回顾
Pub Date : 2021-04-15 DOI: 10.46607/iamj3509042021
Rashmi. B.M
Low back pain is a very common health problem worldwide and a major cause of disability affecting performance at work and general well-being. Though several risk factors have been identified including occupational posture, depressive moods, obesity, body height and age, the causes of the onset of low back pain remain obscure and di- agnosis difficult to make. Low back pain affects people of all ages, from children to the elderly, and is a very fre- quent reason for medical consultations. The 2010 Global Burden of Disease Study estimated that low back pain is among the top 10 diseases. Prevalence increases and peaks between the ages of 35 years and 55 years. Katishula or Low back pain is one of the Vataja Nanatmaja vikaras. The symptoms of Katishula explained in the Classics when compared to Low back pain almost appear similar, so we can co-relate Katishula with Low back pain. Many a times in our clinical practice we come across patients complaining of Katishula (low back pain) as a common symptom which can be seen in many of the diseases with different way of presentation based on the se- verity of the condition. Hence the Present article is built on a detailed historical search on Katishula as per the various classical references, in understanding it merely as a symptom or the disease proper.Keywords: Low back pain, Katishula, Vataja nanatmaja vikara.
腰痛是世界范围内非常常见的健康问题,也是影响工作表现和整体健康的残疾的主要原因。虽然已经确定了几个风险因素,包括职业姿势、抑郁情绪、肥胖、身高和年龄,但腰痛发病的原因仍然不清楚,很难做出诊断。腰痛影响所有年龄段的人,从儿童到老年人,是一个非常频繁的医疗咨询的原因。2010年全球疾病负担研究估计,腰痛是十大疾病之一。患病率在35岁至55岁之间增加并达到高峰。腰痛或腰痛是Vataja Nanatmaja维卡拉之一。与腰痛相比,经典中解释的Katishula的症状几乎是相似的,所以我们可以将Katishula与腰痛联系起来。在我们的临床实践中,我们多次遇到患者抱怨腰痛是一种常见的症状,这种症状可以在许多疾病中看到,根据病情的严重程度有不同的表现方式。因此,本文是根据各种经典文献对卡提舒拉进行详细的历史研究,将其理解为仅仅是一种症状或疾病本身。关键词:腰痛,Katishula, Vataja nanatmaja vikara。
{"title":"AYURVEDA UNDERSTANDING OF KATISHULA (LOW BACK PAIN) AS A VYADHI OR LAKSHANA: A HISTORICAL REVIEW","authors":"Rashmi. B.M","doi":"10.46607/iamj3509042021","DOIUrl":"https://doi.org/10.46607/iamj3509042021","url":null,"abstract":"Low back pain is a very common health problem worldwide and a major cause of disability affecting performance at work and general well-being. Though several risk factors have been identified including occupational posture, depressive moods, obesity, body height and age, the causes of the onset of low back pain remain obscure and di- agnosis difficult to make. Low back pain affects people of all ages, from children to the elderly, and is a very fre- quent reason for medical consultations. The 2010 Global Burden of Disease Study estimated that low back pain is among the top 10 diseases. Prevalence increases and peaks between the ages of 35 years and 55 years. Katishula or Low back pain is one of the Vataja Nanatmaja vikaras. The symptoms of Katishula explained in the Classics when compared to Low back pain almost appear similar, so we can co-relate Katishula with Low back pain. Many a times in our clinical practice we come across patients complaining of Katishula (low back pain) as a common symptom which can be seen in many of the diseases with different way of presentation based on the se- verity of the condition. Hence the Present article is built on a detailed historical search on Katishula as per the various classical references, in understanding it merely as a symptom or the disease proper.\u0000Keywords: Low back pain, Katishula, Vataja nanatmaja vikara.","PeriodicalId":8309,"journal":{"name":"April 2021","volume":"138 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82846722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
REVIEW ON MEDOVAHASROTAS AND ITS MOOLSTHANA WITH REFERENCE TO OBESITY INDUCED HYPERTENSION 关于肥胖高血压的中草药及其草本植物研究进展
Pub Date : 2021-04-15 DOI: 10.46607/iamj2409042021
Jinumon Mathew, Jaishree H Mhaisekar
Excess weight gain, especially when associated with increased visceral adiposity, is a major cause of hypertension accounting 65-75% of total cases of hypertension. Increased renal tubular sodium reabsorption by the impairment in renal pressure natriuresis plays an important role in initiating obesity induced hypertension. The present study conceptually tries to substantiate the relation between moolasthana described for medovahasrotas with reference to the pathology of obesity induced hypertension. The moola explained for medovahasrotas are Kati, Vrikka, Vapavahana and Mamsa (Kidney, Suprarenal gland, Lumbosacral region, Superficial fat) which are the general regions of deposition of visceral fat or meda. The increased meda will hamper the renal pressure natriuresis in mainly three ways:1)Physical compression of the kidneys by fat in and around kidney.2)Increased activation of RAAS.3)Increased SNS activity.Thus, medovaha srotodushti further enhances medodhatudushti (Obesity or Sthoulyata) itself, which in turn destroys the srotomoola. Hence, evidence of inherent relation among medovaha srotas and its respective srotomoola is established.Keywords: Medovahasrotas, Srotomoola, obesity induced hypertension
体重过度增加,特别是与内脏脂肪增加相关时,是高血压的主要原因,占高血压总病例的65-75%。肾小管钠重吸收的增加是由肾压力钠尿损害引起的,在肥胖引起的高血压中起重要作用。本研究从概念上试图证实中西医结合所描述的molasthana与肥胖引起的高血压病理之间的关系。经解释的子宫肌瘤有Kati、Vrikka、Vapavahana和Mamsa(肾脏、肾上腺、腰骶区、浅表脂肪),它们是内脏脂肪或子宫肌瘤沉积的一般区域。肾内及周围脂肪对肾脏的物理压迫,raas的激活增加,SNS的活性增加。因此,medohaha srotodushti进一步增强了medodhatudushti(肥胖或soulyata)本身,这反过来又破坏了srotomoola。因此,建立了梅多哈srotas及其各自的srotomoola之间的内在关系的证据。关键词:梅多瓦氏菌,血吸虫病,肥胖性高血压
{"title":"REVIEW ON MEDOVAHASROTAS AND ITS MOOLSTHANA WITH REFERENCE TO OBESITY INDUCED HYPERTENSION","authors":"Jinumon Mathew, Jaishree H Mhaisekar","doi":"10.46607/iamj2409042021","DOIUrl":"https://doi.org/10.46607/iamj2409042021","url":null,"abstract":"Excess weight gain, especially when associated with increased visceral adiposity, is a major cause of hypertension accounting 65-75% of total cases of hypertension. Increased renal tubular sodium reabsorption by the impairment in renal pressure natriuresis plays an important role in initiating obesity induced hypertension. The present study conceptually tries to substantiate the relation between moolasthana described for medovahasrotas with reference to the pathology of obesity induced hypertension. The moola explained for medovahasrotas are Kati, Vrikka, Vapavahana and Mamsa (Kidney, Suprarenal gland, Lumbosacral region, Superficial fat) which are the general regions of deposition of visceral fat or meda. The increased meda will hamper the renal pressure natriuresis in mainly three ways:\u00001)Physical compression of the kidneys by fat in and around kidney.\u00002)Increased activation of RAAS.\u00003)Increased SNS activity.\u0000Thus, medovaha srotodushti further enhances medodhatudushti (Obesity or Sthoulyata) itself, which in turn destroys the srotomoola. Hence, evidence of inherent relation among medovaha srotas and its respective srotomoola is established.\u0000Keywords: Medovahasrotas, Srotomoola, obesity induced hypertension","PeriodicalId":8309,"journal":{"name":"April 2021","volume":"03 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85963678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MANAGEMENT OF CHITTODWEGA - A CASE REPORT chittodwega的管理- 1例报告
Pub Date : 2021-04-15 DOI: 10.46607/iamj4209042021
Shiddnagouda K B, Roy K. B., Prasannakumari S. Patil
Anxiety is arguably an emotion that predates the evolution of man. Its ubiquity in humans, and its presence in a range of anxiety disorders, makes it an important clinical focus. GAD (Generalised anxiety disorder) is the most common psychiatric disorder characterised by Repeated, Persistent and unrealistic worry about life-events but it is different from normal feelings of anxiousness. The prevalence rate of Anxiety disorder varies according to the different age groupas per the current DSM-5 criteria, only phobia and GAD are included under anxiety disorders, with weighted prevalence values of 4.2% and 5.8% respectively. For these available Psychiatric drugs are having various adverse effect and produces the dependency of the drugs, for this integrated approach is very essential, Ayurveda medicines are safe, cost effective hence here a case of chittodwega is successfully treated withShamana medicine.Keywords: Generalized anxiety disorder, Chittodwega, Ayurveda, Shamana
焦虑可以说是一种早于人类进化的情绪。它在人类中的普遍存在,以及它在一系列焦虑症中的存在,使它成为一个重要的临床焦点。广泛性焦虑障碍(GAD)是最常见的精神障碍,其特征是对生活事件反复、持续和不切实际的担忧,但它与正常的焦虑感觉不同。根据现行DSM-5标准,不同年龄组的焦虑症患病率不同,焦虑症中仅包括恐惧症和广泛性焦虑症,加权患病率分别为4.2%和5.8%。这些现有的精神科药物都有各种各样的副作用,并产生药物依赖性,因为这种综合方法是非常重要的,阿育吠陀药物是安全的,成本有效的,因此这里有一个案例的chittodwega成功地治疗了萨满医学。关键词:广泛性焦虑症,Chittodwega,阿育吠陀,沙玛
{"title":"MANAGEMENT OF CHITTODWEGA - A CASE REPORT","authors":"Shiddnagouda K B, Roy K. B., Prasannakumari S. Patil","doi":"10.46607/iamj4209042021","DOIUrl":"https://doi.org/10.46607/iamj4209042021","url":null,"abstract":"Anxiety is arguably an emotion that predates the evolution of man. Its ubiquity in humans, and its presence in a range of anxiety disorders, makes it an important clinical focus. GAD (Generalised anxiety disorder) is the most common psychiatric disorder characterised by Repeated, Persistent and unrealistic worry about life-events but it is different from normal feelings of anxiousness. The prevalence rate of Anxiety disorder varies according to the different age groupas per the current DSM-5 criteria, only phobia and GAD are included under anxiety disorders, with weighted prevalence values of 4.2% and 5.8% respectively. For these available Psychiatric drugs are having various adverse effect and produces the dependency of the drugs, for this integrated approach is very essential, Ayurveda medicines are safe, cost effective hence here a case of chittodwega is successfully treated with\u0000Shamana medicine.\u0000\u0000Keywords: Generalized anxiety disorder, Chittodwega, Ayurveda, Shamana","PeriodicalId":8309,"journal":{"name":"April 2021","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89687834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
April 2021
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1